Natera (NTRA) Stock Chart - Revenue & Earnings | Quarter Chart

Analyst Forecast

up to date

Select dashboard ▾ New custom dashboard

Income Statement▲

Revenue by Product

ProductLicensing and other

Revenue by Geography

United StatesEurope, Middle East, India, AfricaAmericas, excluding U.S.Asia Pacific and Other

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income

Margin (%)

Gross MarginOperating MarginNet Income Margin

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses

EBITDA

EPS

EPSEPS Diluted

Revenue Variation (%)

Revenue Variation

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation

Revenue YoY Variation (%)

Revenue YoY Variation

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation

Price-to-Earning Ratio

P/E Ratio

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share

Cash Flow Statement▲

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period

Balance Sheet▲

Current Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities

Quick Ratio

Total AssetsTotal Liabilities

Cash & Equivalents

Total Current AssetsTotal Non Current Assets

Total Assets

Total Current LiabilitiesTotal Non Current Liabilities

Total Liabilities

Total Stockholders Equity

Shareholders Equity

Debt To Equity

Asset Composition

Cash And Cash EquivalentsShort Term Investments

Debt Structure

Short Term DebtLong Term Debt

Key Metrics▼

Natera (NTRA) Stock Chart - Revenue & Earnings | Quarter ChartView Natera (NTRA) quarterly revenue, earnings, DCF fair value, and financial charts. Free stock analysis on Quarter Chart.

Natera (NTRA) quarterly earnings & revenue

Natera (NTRA) reported revenue of $696.64M for Q1 2026, up 38.8% year-over-year, with net income of $-85.09M and diluted EPS of $-0.60.

Over the last four reported quarters, Natera generated $2.50B in revenue and $-226.31M in net income.

Natera's next earnings report is scheduled for August 6, 2026; analysts estimate EPS of $-0.49.

Natera quarterly results

Fiscal quarter	Revenue	Revenue YoY	Net income	EPS (diluted)
Q1 2026	$696.64M	+38.8%	$-85.09M	$-0.60
Q4 2025	$665.50M	+39.8%	$47.26M	$0.35
Q3 2025	$592.18M	+34.7%	$-87.54M	$-0.64
Q2 2025	$546.60M	+32.2%	$-100.94M	$-0.74
Q1 2025	$501.83M	+36.5%	$-66.94M	$-0.50
Q4 2024	$476.06M	+53.0%	$-53.77M	$-0.41
Q3 2024	$439.76M	+63.9%	$-31.59M	$-0.26
Q2 2024	$413.35M	+58.1%	$-37.46M	$-0.30

📈 Analysts estimate NTRA EPS of $-0.49 for the upcoming quarter. See Natera revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Natera (NTRA) — frequently asked questions

When does Natera (NTRA) report earnings next?

Natera is expected to report earnings on August 6, 2026. Analysts estimate EPS of $-0.49.

What was NTRA's revenue last quarter?

Natera reported revenue of $696.64M in Q1 2026, up 38.8% from the same quarter a year earlier.

What was NTRA's EPS last quarter?

Natera reported diluted EPS of $-0.60 in Q1 2026.

Is Natera profitable?

Natera is currently not profitable, with $-226.31M in net income over the last four reported quarters.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)

Natera valuation & key metrics →